A new study by a cross-disciplinary research ... to develop a vaccine which will make the immune system produce antibodies that bind effectively to the surface of the hepatitis C virus and thus ...

If none is present, they should get the vaccine again after treating hepatitis C. Previous research had shown that individuals with hepatitis C infection had a lower response to the hepatitis B ...

The hepatitis C virus (HCV), being an RNA virus ... 1) that can provide substantial enhancement to the efficacy of subunit vaccines. Clinical trials are currently underway to determine their ...

American Liver Foundation: “Hepatitis C Treatment.” National Institutes of Health Clinical Trials: “A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or ...

Hepatitis C poses a significant global health ... Furthermore, the only phase II clinical trial conducted with an HCV vaccine candidate proved its inefficacy against chronic infection.

The findings in a study, published in eBioMedicine, specify how important vaccine research and development are for three diseases - malaria, HIV and tuberculosis - that claim 2.5 million lives ...